Welcome!

News Feed Item

IBM Watson Ushers in a New Era of Data-Driven Discoveries

- Next Milestone in Cognitive Computing is Accelerating Scientific and Industrial Research

NEW YORK, Aug. 28, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced significant advances in Watson's cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.

IBM Corporation logo.

Available now as a cloud service, IBM's Watson Discovery Advisor is designed to scale and accelerate discoveries by research teams. It reduces the time needed to test hypotheses and formulate conclusions that can advance their work -- from months to days and days to just hours -- bringing new levels of speed and precision to research and development.

Building on Watson's ability to understand nuances in natural language, Watson Discovery Advisor can understand the language of science, such as how chemical compounds interact, making it a uniquely powerful tool for researchers in life sciences and other industries. 

Researchers and scientists from leading academic, pharmaceutical and other commercial research centers have begun deploying IBM's new Watson Discovery Advisor to rapidly analyze and test hypotheses using data in millions of scientific papers available in public databases. A new scientific research paper is published nearly every 30 seconds, which equals more than a million annually (Source: CiteSeerx). According to the National Institutes of Health, a typical researcher reads about 23 scientific papers per month, which translates to nearly 300 per year, making it humanly impossible to keep up with the ever-growing body of scientific material available.

In 2013, the top 1,000 research and development companies spent more than $600 billion annually on research alone (Source: Strategy&). Progress can be slow, taking an average of 10 to 15 years for a promising pharmaceutical treatment to progress from the initial research stage into practice (Source: Pharmaceutical Research and Manufacturers of America). Using Watson Discovery Advisor, researchers can uncover new relationships and recognize unexpected patterns among data that have the potential to significantly improve and accelerate the discovery process in research and science.

"We're entering an extraordinary age of data-driven discovery," said Mike Rhodin, senior vice president, IBM Watson Group. "Today's announcement is a natural extension of Watson's cognitive computing capability. We're empowering researchers with a powerful tool which will help increase the impact of investments organizations make in R&D, leading to significant breakthroughs."

Leading life sciences organizations are deploying Watson Discovery Advisor to advance discoveries in ongoing research projects, including Baylor College of Medicine, Johnson & Johnson and The New York Genome Center.

  • In a retrospective, peer reviewed study released this week by Baylor College of Medicine and IBM, scientists demonstrated a possible new path for generating scientific questions that may be helpful in the long term development of new, effective treatments for disease. In a matter of weeks, biologists and data scientists using the Baylor Knowledge Integration Toolkit (KnIT), based on Watson technology, accurately identified proteins that modify p53, an important protein related to many cancers, which can eventually lead to better efficacy of drugs and other treatments. A feat that would have taken researchers years to accomplish without Watson's cognitive capabilities, Watson analyzed 70,000 scientific articles on p53 to predict proteins that turn on or off p53's activity. This automated analysis led the Baylor cancer researchers to identify six potential proteins to target for new research. These results are notable, considering that over the last 30 years, scientists averaged one similar target protein discovery per year. 

"On average, a scientist might read between one and five research papers on a good day," said Dr. Olivier Lichtarge, the principal investigator and professor of molecular and human genetics, biochemistry and molecular biology at Baylor College of Medicine. "To put this in perspective with p53, there are over 70,000 papers published on this protein. Even if I'm reading five papers a day, it could take me nearly 38 years to completely understand all of the research already available today on this protein. Watson has demonstrated the potential to accelerate the rate and the quality of breakthrough discoveries."

  • Johnson & Johnson is collaborating with the IBM Watson Discovery Advisor team to teach Watson to read and understand scientific papers that detail clinical trial outcomes used to develop and evaluate medications and other treatments. This collaboration hopes to accelerate comparative effectiveness studies of drugs, which help doctors match a drug with the right set of patients to maximize effectiveness and minimize side effects. Typically, comparative effectiveness studies are done manually, requiring three people to spend an average of 10 months (2.5 man-years) just to collect the data and prepare them for use before they are able to start analyzing, generating and validating a hypothesis. In this research study, the team hopes to teach Watson to quickly synthesize the information directly from the medical literature, allowing researchers to start asking questions about the data immediately to determine the effectiveness of a treatment compared to other medications, as well as its side effects. 
  • IBM Watson will be supporting the analysis in New York Genome Center's clinical study to advance genomic medicine. The clinical study will initially focus on clinical application of genomics to help oncologists deliver DNA-based treatment for glioblastoma, an aggressive form of brain cancer that kills more than 13,000 Americans each year. Despite tremendous discoveries into the genetic drivers of diseases like cancer over the past decade, big data makes it difficult to translate DNA data into life-saving treatments. Based on results from the clinical study, IBM Watson could soon help scale up the availability of personalized treatment options.

Industry Implications 

Discovering something new is applicable to many domains such as medicine, law, finance, etc., that all require deep insight into a large body of information and protocols. Cognitive computing will allow human experts to interact with large bodies of data and research and the knowledge and insight of many other experts in their field. For example, Watson could be used to:

  • Accelerate a medical researcher's ability to develop life-saving treatments for diseases by synthesizing evidence and removing reliance on serendipity
  • Enhance a financial analyst's ability to provide proactive advice to clients
  • Improve a lawyer's merger and acquisition strategy with faster, more comprehensive due diligence and document analysis
  • Accelerate a government analyst's insight into security, intelligence, border protection and law enforcement and guidance, etc.
  • Create new food recipes. Chefs can use Watson to augment their creativity and expertise and help them discover recipes, learning about the language of cooking and food by reading recipes, statistical, molecular and food pairing theories, hedonic chemistry, as well as regional and cultural knowledge

IBM Watson Discovery Advisor has the potential to transform industries and professions that rely heavily on data, including law, pharmaceuticals, biotech, education, chemicals, metals, scientific research, engineering, and criminal investigations. For more information, visit https://ibm.biz/watsondiscoveryadvisor.

IBM Power Systems serves as the infrastructure base of Watson, supporting the high volume of data needed to drive cognitive insights.

Photos are available via the Associated Press Photo Network and on the Internet at Feature Photo Service's link through http://www.newscom.com

IBM Watson: Pioneering a New Era of Computing
Three years after its victory on the TV quiz show Jeopardy!, IBM Watson has evolved to represent a new era of computing, earning recognition from Frost & Sullivan, which presented IBM Watson with the 2013 North America Award for New Product Innovation, and Gartner Inc., which cites IBM Watson in its Top 10 Strategic Technology Trends for 2014 and predicts that by 2017, 10 percent of computers will be able to learn as Watson does.

Today, Watson is no longer just the world's most famous game-playing computer. IBM has put Watson to work in various industries. In healthcare, IBM is co-developing an application with Memorial Sloan-Kettering Cancer Center, and partnering with WellPoint, the University of Texas MD Anderson Cancer Center, and the Cleveland Clinic Lerner College of Medicine.  Additionally, IBM has partnered with numerous colleges and universities across the country to teach Watson capabilities and cognitive computing technology to the next generation workforce.

For more information on IBM Watson, please visit: www.ibmwatson.com

To join the social discussion about Watson, include the hashtag #ibmwatson. Follow Watson on Facebook and see Watson on YouTube and Flickr.

Journalists and bloggers can download a video and images about IBM Watson Discovery by clicking here.

For more insights on this story please read these posts on IBM's A Smarter Planet blog: ibm.co/1tFVdly, ibm.co/XPzxIY, ibm.co/1vj8dQZ

Media Contacts

Tod Freeman
IBM Media Relations
(415) 320-5893
[email protected]

John Connolly
IBM Media Relations
(781) 636-8512
[email protected]

Logo - http://photos.prnewswire.com/prnh/20090416/IBMLOGO

SOURCE IBM

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"Avere Systems deals with data performance optimization in the cloud or on-premise. Even to this day many organizations struggle with what we call the problem of data gravity - 'Where should I put the data?' - because the data dictates ultimately where the jobs are going to run," explained Scott Jeschonek, Director Cloud Solutions at Avere Systems, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
For years the world's most security-focused and distributed organizations - banks, military/defense agencies, global enterprises - have sought to adopt cloud technologies that can reduce costs, future-proof against data growth, and improve user productivity. The challenges of cloud transformation for these kinds of secure organizations have centered around data security, migration from legacy systems, and performance. In our presentation, we will discuss the notion that cloud computing, properl...
They say multi-cloud is coming, but organizations are leveraging multiple clouds already. According to a study by 451 Research, only 21% of organizations were using a single cloud. If you've found yourself unprepared for the barrage of cloud services introduced in your organization, you will need to change your approach to engaging with the business and engaging with vendors. Look at technologies that are on the way and work with the internal players involved to have a plan in place when the ine...
"We began as LinuxAcademy.com about five years ago as a very small outfit. Since then we've transitioned into more of a DevOps training company - the technologies and the tooling around DevOps," explained Doug Vanderweide, an instructor at Linux Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes how...
CloudEXPO New York 2018, colocated with DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
DevOps with IBMz? You heard right. Maybe you're wondering what a developer can do to speed up the entire development cycle--coding, testing, source code management, and deployment-? In this session you will learn about how to integrate z application assets into a DevOps pipeline using familiar tools like Jenkins and UrbanCode Deploy, plus z/OSMF workflows, all of which can increase deployment speeds while simultaneously improving reliability. You will also learn how to provision mainframe syste...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
Organizations planning enterprise data center consolidation and modernization projects are faced with a challenging, costly reality. Requirements to deploy modern, cloud-native applications simultaneously with traditional client/server applications are almost impossible to achieve with hardware-centric enterprise infrastructure. Compute and network infrastructure are fast moving down a software-defined path, but storage has been a laggard. Until now.